Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
November 22, 2016
The article describes the Face2Gene app developed by FDNA, which leverages advanced facial recognition technology to enhance the diagnosis of genetic disorders. By analyzing facial images, the app assists healthcare professionals in identifying specific syndromes more accurately and efficiently. This innovative approach not only streamlines the diagnostic process but also improves patient care by providing comprehensive evaluations based on facial features. With its user-friendly interface, Face2Gene represents a significant advancement in genetic diagnostics, bridging the gap between phenotype analysis and clinical practice.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…